Clinical trial
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
NCT00000769 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- April 30, 1998
- Enrollment
- 48
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.